Home Tags Patent

Tag: Patent

Google Fined $32.5M For Infringing On Sonos Patent

According to Reuters, Sonos has been awarded $32.5 million by a court, as Google was found to have violated the company's smart speaker patent. On Friday,...

Nokia Calls New EU Patent Laws One-Sided

Nokia has expressed concerns that the draft rules proposed by the EU to prevent disputes over patents for telecoms equipment and connected cars could...

SCOTUS Asked To Rule On Whether AI Can Be A Patent...

Computer scientist Stephen Thaler petitioned the US Supreme Court on Friday to hear his case concerning the international patenting of inventions created by his...

Why Do Judges Compete for (Patent) Cases?

By Paul R. Gugliuzza & Jonas Andreson, Temple University It’s not just parties to litigation who forum shop. Sometimes judges forum sell by trying...
The Emerging High-Court Jurisprudence On The Antitrust Analysis Of Multisided Platforms

Rethinking Patent Law’s Exclusive Appellate Jurisdiction

By Christa Laser, Cleveland-Marshall College of Law. The United States Court of Appeals for the Federal Circuit was created in 1982 to unify and clarify...
Apple

Apple Wins Appeal Of App Maker’s Patent Antitrust Suit

Apple persuaded an appeals court on Tuesday to reject a US patent and antitrust lawsuit by email app maker Blix Inc that accused the...
Pharma

A Simple Solution to the Problem of ‘Product Hopping’

By Michael A. Carrier (Rutgers Law School) Brand-name drug companies frequently switch from one version of a drug to another. Sometimes, the switch is made...
Google

Google Wins Patent Trial In Texas

Google’s Nest Hub doesn’t infringe a patent owned by Profectus Technology for a digital picture frame, a federal jury in Waco, Texas, found. The...
Consumer Welfare

Why Patent Monopsonies Increase Consumer Welfare

By Bernard Chao & Tod Duncan (University of Denver Sturm College of Law) Technical standards are an essential part of how the modern world operates....
Takeda

Takeda Loses Antitrust Appeal Over Patent Listing

Takeda Pharmaceutical must face antitrust litigation over its alleged scheme to delay generic versions of the diabetes drug Actos by exaggerating the scope of...
Enable Notifications    OK No thanks